4-[N,N-bis-(2-hydroxyethyl)amino]butanoic acid | 765250-80-4

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: 4-[N,N-bis-(2-hydroxyethyl)amino]butanoic acid
• 英文别名: 4-[Bis(2-hydroxyethyl)amino]butanoic acid
• CAS: 765250-80-4
• 化学式: C₈H₁₇NO₄
• 分子量: 191.227
• InChiKey: PRLFPCSUDDWZSY-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -3.5
• 重原子数：
  13
• 可旋转键数：
  8
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.88
• 拓扑面积：
  81
• 氢给体数：
  3
• 氢受体数：
  5

文献信息

• EP0839032A4
  申请人：——

  公开号：EP0839032A4

  公开（公告）日：1998-07-08
• HYDROXYL IONS AS UNIQUE THERAPEUTIC AGENTS AND COMPOUNDS THAT MODULATE IONS, COMPOUNDS
  申请人：FHJ SCIENTIFIC, INC.

  公开号：EP0839032A1

  公开（公告）日：1998-05-06
• SOLID ELECTROLYTE COMPOSITION, SOLID ELECTROLYTE-CONTAINING SHEET AND MANUFACTURING METHOD THEREFOR, ALL-SOLID STATE SECONDARY BATTERY AND MANUFACTURING METHOD THEREFOR, POLYMER AND NON-AQUEOUS SOLVENT DISPERSION THEREOF, AND DIOL COMPOUND
  申请人：FUJIFILM Corporation

  公开号：US20190348709A1

  公开（公告）日：2019-11-14

  Provided are a solid electrolyte composition containing an inorganic solid electrolyte having a conductivity of an ion of a metal belonging to Group I or II of the periodic table and a binder having a specific constituent component, a solid electrolyte-containing sheet in which the same solid electrolyte composition is used and a manufacturing method therefor, an all-solid state secondary battery and a manufacturing method therefor, a polymer having a specific constituent component, a non-aqueous solvent dispersion thereof, and a dial compound.
• US5679711A
  申请人：——

  公开号：US5679711A

  公开（公告）日：1997-10-21
• [EN] HYDROXYL IONS AS UNIQUE THERAPEUTIC AGENTS AND COMPOUNDS THAT MODULATE IONS, COMPOUNDS<br/>[FR] IONS HYDROXYLE A TITRE D'AGENTS THERAPEUTIQUES PARTICULIERS, ET COMPOSES APTES A MODULER CES IONS, COMPOSES
  申请人：FHJ SCIENTIFIC, INC.

  公开号：WO1996040104A1

  公开（公告）日：1996-12-19

  (EN) The invention concerns the discovery of the surprising and unexpected therapeutic effects of hydroxyl ions. The observed medicinalproperties of these ions are both novel and broad in scope. The acute corrosive effects and toxicity of hydroxyl ions on living tissue has previously overwhelmed their therapeutic attributes. Unique hydroxyl ion modulating compounds have been discovered and are within the scope of the invention. When used appropriately as companions with hydroxyl ions, these modulating compounds obviate and attenuate the harmful effects of hydroxyl ions, unmasking andrevealing their previously unknown and undemonstratable therapeutic properties. These hydroxyl ion modulating compounds do not significantly interfere with the surprising and unexpected therapeutic benefits of the hydroxyl ions. The novel hydroxyl ion modulating compounds are generally characterized as N,N-disubstituted-aminoalkanoate salts and substituted N,N-substituted-aminoalkanoate salts.(FR) On a découvert les effets thérapeutiques surprenants et inattendus des ions hydroxyle. Les propriétés médicinales observées de ces ions sont à la fois nouvelles et vastes. Les effets corrosifs aigus et la toxicité des ions hydroxyle vis-à-vis des tissus vivants l'ont jusqu'ici emporté sur leurs propriétés thérapeutiques. On a découvert des composés particuliers aptes à moduler les ions hydroxyle, et ils sont compris dans l'étendue de l'invention. Utilisés de manière appropriée en association avec les ions hydroxyle, ces composés neutralisent et atténuent les effets néfastes des ions hydroxyle, car ils mettent en évidence leurs propriétés thérapeutiques que l'on ne pouvait ni connaître ni démontrer auparavant. Lesdits composés modulateurs d'ions hydroxyle n'ont aucune influence notable sur les effets bénéfiques surprenants et inattendus des ions hydroxyle. Ces nouveaux composés modulateurs d'ions hydroxyle sont généralement des sels aminoalcanoate N,N-disubstitués et des sels aminoalcanoate N,N-substitués.